Literature DB >> 12675542

Prostate-specific antigen testing. Should we recommend it?

John Hickey1.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12675542      PMCID: PMC2214193     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  12 in total

Review 1.  Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer.

Authors:  M J Barry
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

2.  Effect of ejaculation on serum total and free prostate-specific antigen concentrations.

Authors:  J D Herschman; D S Smith; W J Catalona
Journal:  Urology       Date:  1997-08       Impact factor: 2.649

3.  Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.

Authors:  B Djavan; A Zlotta; M Remzi; K Ghawidel; A Basharkhah; C C Schulman; M Marberger
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

4.  Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements.

Authors:  W J Catalona; D S Smith; D K Ornstein
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

Review 5.  Prostate specific antigen: biology, biochemistry and available commercial assays.

Authors:  A M Ward; J W Catto; F C Hamdy
Journal:  Ann Clin Biochem       Date:  2001-11       Impact factor: 2.057

6.  Validity of the prostate specific antigen test for prostate cancer screening: followup study with a bank of 21,000 sera in Finland.

Authors:  M Hakama; U H Stenman; A Aromaa; J Leinonen; T Hakulinen; P Knekt
Journal:  J Urol       Date:  2001-12       Impact factor: 7.450

7.  The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan.

Authors:  S Egawa; S Soh; M Ohori; T Uchida; K Gohji; A Fujii; S Kuwao; K Koshiba
Journal:  Cancer       Date:  1997-01-01       Impact factor: 6.860

8.  Prostate-specific antigen testing of older men.

Authors:  H B Carter; P K Landis; E J Metter; L A Fleisher; J D Pearson
Journal:  J Natl Cancer Inst       Date:  1999-10-20       Impact factor: 13.506

9.  PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/mL.

Authors:  B Djavan; A Zlotta; C Kratzik; M Remzi; C Seitz; C C Schulman; M Marberger
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

10.  The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng/ml: relation to biopsy strategy.

Authors:  R J Babaian; D A Johnston; W Naccarato; A Ayala; V A Bhadkamkar; H A Fritsche HA
Journal:  J Urol       Date:  2001-03       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.